Protein repair (Homo sapiens)

From WikiPathways

Jump to: navigation, search
91, 5, 8624, 71063cytosolH2OL-Asp MSRB2 L-Asp,isoAspisoAsp isoAspisoAsp L-Met2xHC-TXNAdoMetMSRAL-methionine (S)-S-oxide MSRB3 PCMT1AdoHcyH2OL-Arg L-methionine(S)-S-oxideL-Arg,L-AsnL-Asp MSRB1 L-Asn L-Asp,isoAspL-methionine (R)-S-oxide L-methionine(R)-S-oxideTXNH2O2MetOOMetOMetAspMSRBs


Description

Reactive oxygen species (ROS) such as H2O2, superoxide anions and hydroxyl radicals interact with molecules in the cell causing damage that impairs cellular functions. Although cells have mechanisms to destroy ROS and repair the damage caused by ROS, it is considered to be a major factor in age-related diseases and the ageing process (Zhang & Weissbach 2008, Kim et al. 2014). ROS-scavenging systems include enzymes such as peroxiredoxins, superoxide dismutases, catalases and glutathione peroxidases exist to minimise the potential damage.

ROS reactions can also cause specific modifications to amino acid side chains that result in structural changes to proteins/enzymes. Methionine (Met) and cysteine (Cys) can be oxidised by ROS to sulfoxide and further oxidised to sulfone derivatives. Both free Met and protein-based Met are readily oxidized to form methionine sulphoxide (MetO) (Brot & Weissbach 1991). Many proteins have been demonstrated to undergo such oxidation and as a consequence have altered function (Levine et al. 2000). Sulphoxide formation can be reversed by the action of the methionine sulphoxide reductase system (MSR) which catalyses the reduction of MetO to Met (Brot et al. 1981). This repair uses one ROS equivalent, so MSR proteins can act as catalytic antioxidants, removing ROS (Levine et al. 1996). Methionine oxidation results in a mixture of methionine (S)-S- and (R)-S-oxides of methionine, diastereomers which are reduced by MSRA and MSRB, respectively. MSRA can reduce both free and protein-based methionine-(S)-S-oxide, whereas MSRB is specific for protein-based methionine-(R)-S-oxide. Mammals typically have only one gene encoding MSRA, but at least three genes encoding MSRBs (Hansel et al. 2005). Although structurally distinct, MRSA and MRSB share a common three-step catalytic mechanism. In the first step, the MSR catalytic cysteine residue interacts with the MetO substrate, which leads to product release and formation of the sulfenic acid. In the second step, an intramolecular disulfide bridge is formed between the catalytic cysteine and the regenerating cysteine. In the final step, the disulfide bridge is reduced by an electron donor, the NADPH-dependent thioredoxin/TR system, leading to the regeneration of the MSR active site (Boschi-Muller et al. 2008).

Beta-linked isoaspartyl (isoAsp) peptide bonds can arise spontaneously via succinimide-linked deamidation of asparagine (Asn) or dehydration of aspartate (Asp). Protein-L-isoaspartate (D-aspartate) O-methyltransferase (PCMT1, PIMT EC 2.1.1.77) transfers the methyl group from S-adenosyl-L-methionine (AdoMet) to the alpha side-chain carboxyl group of L-isoaspartyl and D-aspartatyl amino acids. The resulting methyl ester undergoes spontaneous transformation to L-succinimide, which spontaneously hydrolyses to generates L-aspartyl residues or L-isoaspartyl residues (Knorre et al. 2009). This repair process helps to maintain overall protein integrity. View original pathway at Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 5676934
Reactome-version 
Reactome version: 75
Reactome Author 
Reactome Author: Jupe, Steve

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Huang W, Escribano J, Sarfarazi M, Coca-Prados M.; ''Identification, expression and chromosome localization of a human gene encoding a novel protein with similarity to the pilB family of transcriptional factors (pilin) and to bacterial peptide methionine sulfoxide reductases.''; PubMed Europe PMC Scholia
  2. Kuschel L, Hansel A, Schönherr R, Weissbach H, Brot N, Hoshi T, Heinemann SH.; ''Molecular cloning and functional expression of a human peptide methionine sulfoxide reductase (hMsrA).''; PubMed Europe PMC Scholia
  3. Nielsen HK, Löliger J, Hurrell RF.; ''Reactions of proteins with oxidizing lipids. 1. Analytical measurements of lipid oxidation and of amino acid losses in a whey protein-methyl linolenate model system.''; PubMed Europe PMC Scholia
  4. Johnson BA, Langmack EL, Aswad DW.; ''Partial repair of deamidation-damaged calmodulin by protein carboxyl methyltransferase.''; PubMed Europe PMC Scholia
  5. Jung S, Hansel A, Kasperczyk H, Hoshi T, Heinemann SH.; ''Activity, tissue distribution and site-directed mutagenesis of a human peptide methionine sulfoxide reductase of type B: hCBS1.''; PubMed Europe PMC Scholia
  6. Clarke S.; ''Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins.''; PubMed Europe PMC Scholia
  7. Takeda R, Mizobuchi M, Murao K, Sato M, Takahara J.; ''Characterization of three cDNAs encoding two isozymes of an isoaspartyl protein carboxyl methyltransferase from human erythroid leukemia cells.''; PubMed Europe PMC Scholia
  8. Kryukov GV, Kryukov VM, Gladyshev VN.; ''New mammalian selenocysteine-containing proteins identified with an algorithm that searches for selenocysteine insertion sequence elements.''; PubMed Europe PMC Scholia
  9. Kim G, Weiss SJ, Levine RL.; ''Methionine oxidation and reduction in proteins.''; PubMed Europe PMC Scholia
  10. LAVINE TF.; ''The formation, resolution, and optical properties of the diastereoisomeric sulfoxides derived from L-methionine.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114843view16:34, 25 January 2021ReactomeTeamReactome version 75
113289view11:35, 2 November 2020ReactomeTeamReactome version 74
112501view15:46, 9 October 2020ReactomeTeamReactome version 73
101413view11:29, 1 November 2018ReactomeTeamreactome version 66
100951view21:06, 31 October 2018ReactomeTeamreactome version 65
100488view19:40, 31 October 2018ReactomeTeamreactome version 64
100033view16:23, 31 October 2018ReactomeTeamreactome version 63
99586view14:57, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
93788view13:36, 16 August 2017ReactomeTeamreactome version 61
93322view11:20, 9 August 2017ReactomeTeamreactome version 61
88123view10:12, 26 July 2016RyanmillerOntology Term : 'peptide and protein metabolic process' added !
88122view10:11, 26 July 2016RyanmillerOntology Term : 'classic metabolic pathway' added !
86409view09:17, 11 July 2016ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
2xHC-TXNProteinP10599 (Uniprot-TrEMBL)
AdoHcyMetaboliteCHEBI:16680 (ChEBI)
AdoMetMetaboliteCHEBI:15414 (ChEBI)
H2O2MetaboliteCHEBI:16240 (ChEBI)
H2OMetaboliteCHEBI:15377 (ChEBI)
L-Arg MetaboliteCHEBI:32682 (ChEBI)
L-Arg,L-AsnComplexR-ALL-5687524 (Reactome)
L-Asn MetaboliteCHEBI:58048 (ChEBI)
L-Asp MetaboliteCHEBI:29991 (ChEBI)
L-Asp,isoAspComplexR-ALL-5687535 (Reactome)
L-MetMetaboliteCHEBI:57844 (ChEBI)
L-methionine (R)-S-oxideMetaboliteCHEBI:49032 (ChEBI)
L-methionine (S)-S-oxideMetaboliteCHEBI:49031 (ChEBI)
L-methionine (R)-S-oxide MetaboliteCHEBI:49032 (ChEBI)
L-methionine (S)-S-oxide MetaboliteCHEBI:49031 (ChEBI)
MSRAProteinQ9UJ68 (Uniprot-TrEMBL)
MSRB1 ProteinQ9NZV6 (Uniprot-TrEMBL)
MSRB2 ProteinQ9Y3D2 (Uniprot-TrEMBL)
MSRB3 ProteinQ8IXL7 (Uniprot-TrEMBL)
MSRBsComplexR-HSA-5676939 (Reactome)
MetAspMetaboliteCHEBI:31882 (ChEBI)
MetOOMetaboliteCHEBI:21363 (ChEBI)
MetOComplexR-ALL-5676943 (Reactome)
PCMT1ProteinP22061 (Uniprot-TrEMBL)
TXNProteinP10599 (Uniprot-TrEMBL)
isoAsp MetaboliteCHEBI:85309 (ChEBI)
isoAspMetaboliteCHEBI:85309 (ChEBI)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
2xHC-TXNArrowR-HSA-5676917 (Reactome)
2xHC-TXNArrowR-HSA-5676940 (Reactome)
AdoHcyArrowR-HSA-5676966 (Reactome)
AdoMetR-HSA-5676966 (Reactome)
H2O2R-HSA-5676912 (Reactome)
H2O2R-HSA-5676926 (Reactome)
H2OArrowR-HSA-5676912 (Reactome)
H2OArrowR-HSA-5676926 (Reactome)
L-Arg,L-AsnR-HSA-5685345 (Reactome)
L-Asp,isoAspArrowR-HSA-5685345 (Reactome)
L-Asp,isoAspArrowR-HSA-5687520 (Reactome)
L-MetArrowR-HSA-5676917 (Reactome)
L-MetArrowR-HSA-5676940 (Reactome)
L-MetR-HSA-5676912 (Reactome)
L-methionine (R)-S-oxideR-HSA-5676917 (Reactome)
L-methionine (S)-S-oxideR-HSA-5676940 (Reactome)
MSRAmim-catalysisR-HSA-5676940 (Reactome)
MSRBsmim-catalysisR-HSA-5676917 (Reactome)
MetAspArrowR-HSA-5676966 (Reactome)
MetAspR-HSA-5687520 (Reactome)
MetOArrowR-HSA-5676912 (Reactome)
MetOOArrowR-HSA-5676926 (Reactome)
MetOR-HSA-5676926 (Reactome)
PCMT1mim-catalysisR-HSA-5676966 (Reactome)
R-HSA-5676912 (Reactome) Methionine can be oxidised by naturally-occurring reactive oxygen species (ROS) such as hydrogen peroxide (H2O2) to form methionine sulfoxide (MetO), and by further oxidation to a methyl sulfone derivative (MetOO). Oxidation of methionine results in a mixture of the diastereomers methionine-(S)-S-oxide and methionine-(R)-S-oxide (Lavine 1947, Kim et al. 2014).
R-HSA-5676917 (Reactome) Methionine Sulfoxide Reductase B (MSRBs) are able to reduce methyl-(R)-S-oxide to methionine (Grimaud et al. 2001). They are specific for the reduction of protein-based methyl-(R)-S-oxide, reducing free methyl-(R)-S-oxide with very low efficiency (Lee et al. 2009). Mammals have at least 3 MSRB genes (Kryukov et al. 1999, Huang et al. 1999, Jung et al. 2002, Kim & Gladyshev 2004). They are ubiquitously expressed, no clear substrate specificities are known, all three contain a zinc atom and can use thioredoxin as an in vivo reducing agent (Kim & Gladyshev 2007).
R-HSA-5676926 (Reactome) The major oxidation product of protein-bound methionine is methionine sulfoxide. This can be further oxidised to methionine sulfone (Nielsen et al. 1985).
R-HSA-5676940 (Reactome) Methionine Sulfoxide Reductase A (MSRA) is a peptide-methionine-(S)-S-oxide reductase (1.8.4.11.) (Kim & Gladyshev 2007, Sreekumar et al. 2011) that can reduce both free and protein-based methionine-(S)-S-oxide (Brot et al. 1981, Boschi-Muller et al. 2008). It has been implicated in processes ranging from protection of cells against oxidative damage to the maintenance of cellular homeostasis, prevention of disease and extension of longevity (Kim & Gladyshev 2007, Brennan & Kantorow 2009). MRSA has little or no target specificity and is therefore likely to act on surface-exposed methionine sulphoxide residues of many proteins (Weissbach et al. 2002, Kantorow et al. 2012).
R-HSA-5676966 (Reactome) Protein-L-isoaspartate (D-aspartate) O-methyltransferase (PCMT1, PIMT EC 2.1.1.77) transfers the methyl group from S-adenosyl-L-methionine (AdoMet) to the alpha side-chain carboxyl group of L-isoaspartyl and D-aspartatyl amino acids (Murray & Clarke 1986, Johnson et al. 1987, Galletti et al. 1988, Lowenson & Clarke 1992, The resulting methyl ester (MetAsp) undergoes spontaneous transformation to L-succinimide, which spontaneously hydrolyses to generates L-aspartyl residues or L-isoaspartyl residues. This repair process helps to maintain overall protein integrity. When PCMT1 is not present in cells, the abnormal aspartyl residues accumulate. Pcmt1 knockout mice exhibit fatal progressive epilepsy (Yamamoto et al. 1998).
R-HSA-5685345 (Reactome) Beta-linked isoaspartyl (isoAsp) peptide bonds can arise spontaneously via succinimide-linked deamidation of asparagine (Asn) or dehydration of aspartate (Asp). The peptide bond becomes linked through the beta-carboxyl group of the Asp or Asn side-chain, leaving the alpha-carboxyl group of the original peptide bond free. The symmetry of the resulting succinimide intermediate leads to two possible products, either aspartate or isoaspartate, which is an atypical beta-amino acid. The mechanism favours approximately 7:3 the 'iso' form (Bornstein & Balian 1977, Aswad 1984, Murray & Clarke 1984, Di Donato et al. 1986). Formation of the succinimidyl intermediate and its cleavage occur spontaneously. The propensity to form isoaspartyl linkages depends on the residues flanking the asparaginyl site, with small resdiues such as Gly favouring linkage formation, as well as on the local conformation and flexibility of the polypeptide chain (Clarke 1987, Galletti et al. 1989).

These reactions are a significant source of protein damage under physiological conditions and represent both a mechanism that can usefully determine the lifetime of a protein (Robinson et al. 1970) and a component of the pathological process of ageing (Clarke 2003).
R-HSA-5687520 (Reactome) The methyl ester produced by the action of PCMT1 on L-isoaspartyl and D-aspartatyl amino acids subsequently undergoes spontaneous transformation to L-succinimide, which further spontaneously hydrolyses to generates L-aspartyl residues or L-isoaspartyl residues (Murray & Clarke 1986, Johnson et al. 1987, Galletti et al. 1988, Lowenson & Clarke 1992). This repair process helps to maintain overall protein integrity. When PCMT1 is not present in cells, the abnormal aspartyl residues accumulate. Pcmt1 knockout mice exhibit fatal progressive epilepsy (Yamamoto et al. 1998).
TXNR-HSA-5676917 (Reactome)
TXNR-HSA-5676940 (Reactome)
isoAspR-HSA-5676966 (Reactome)
Personal tools